About this trial
This randomized clinical trial investigates the effects of a home-based multicomponent exercise program (Vivifrail) on physical function, muscle morphology, and cognition in community-dwelling adults aged 90 years and older. Participants are randomized into three groups: Vivifrail at least twice a week, Vivifrail at least three times a week, or a control group. Outcomes are assessed at baseline, 12 weeks, and 24 weeks. The primary outcome is physical function measured by the Short Physical Performance Battery (SPPB).
Eligibility criteria
Qualifiers
Aged 90 years or older
Living in the community (own or family home)
Able to walk independently or with a walking aid (cane or walker), without third-party assistance
Minimum cognitive capacity to understand and perform the exercises (MMSE, education-adjusted cutoffs)
Disqualifiers
- Total inability to walk or permanent bedridden condition
Severe cognitive impairment preventing safe understanding and execution of exercises
Severe orthopedic, neurological, or rheumatological conditions preventing exercise
Concurrent participation in another structured exercise program
Trial design
Treatments tested in this trial
- Vivifrail multicomponent exercise program